Periodontal therapy effects on nitrite related to oral bacteria: A 6-month randomized clinical trial

Journal of Periodontology

Volumn 86, Issue 8, 2015, Pages 984-994

  Cortelli, Sheila C ^a,b   Costa, Fernando O ^b   Rodrigues, Edson ^a   Cota, Luis O M ^b   Cortelli, Jose R ^a  

^a UNIVERSITY OF TAUBATÉ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Bacteria; Nitrites; Periodontal diseases; Randomized controlled trial; Therapeutics

Indexed keywords

CHLORHEXIDINE; MOUTHWASH; NITRITE; PLACEBO; TOPICAL ANTIINFECTIVE AGENT;

ACTINOMYCES; ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; BACTERIAL LOAD; BACTERIUM; CHEMISTRY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DENTAL DEBRIDEMENT; DENTAL SCALING; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PORPHYROMONAS GINGIVALIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SALIVA; STREPTOCOCCUS ORALIS; TANNERELLA FORSYTHIA; TREPONEMA DENTICOLA;

ACTINOMYCES; ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIA; BACTERIAL LOAD; CHLORHEXIDINE; CHRONIC PERIODONTITIS; DENTAL SCALING; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTHWASHES; NITRITES; PERIODONTAL DEBRIDEMENT; PLACEBOS; PORPHYROMONAS GINGIVALIS; SALIVA; STREPTOCOCCUS ORALIS; TANNERELLA FORSYTHIA; TREPONEMA DENTICOLA;

EID: 84938260831     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2015.140678     Document Type: Article

References (52)

1. Quirynen M, Bollen CM, Vandekerckhove BN, Dekeyser C, Papaioannou W, Eyssen H. Full-vs. partial-mouth disinfection in the treatment of periodontal infections: Short-term clinical and microbiological observations. J Dent Res 1995;74:1459-1467.
2. Cortelli SC, Cortelli JR, Holzhausen M, et al. Essential oils in one-stage full-mouth disinfection: Double-blind, randomized clinical trial of long-term clinical, microbial and salivary effects. J Clin Periodontol 2009;36:333-342.
3. Alwaeli HA, Al-Khateeb SN, Al-Sadi A. Long-term clinical effect of adjunctive antimicrobial photodynamic therapy in periodontal treatment: A randomized clinical trial. Lasers Med Sci 2015;30:801-807.
4. Sahrmann P, Imfeld T, Ronay V, Attin T, Schmidlin PR. Povidone-iodine gel and solution as adjunct to ultrasonic debridement in nonsurgical periodontitis treatment: An RCT pilot study. Quintessence Int 2014;45:281-290.
5. Razzouk S, Termechi O. Host genome, epigenome, and oral microbiome interactions: Toward personalized peri-odontal therapy. J Periodontol 2013;84:1266-1271.
6. Gokhale SR, Padhye AM. Future prospects of systemic host modulatory agents in periodontal therapy. Br Dent J 2013;214:467-471.
7. Pereira C, Ferreira NR, Rocha BS, Barbosa RM, Laranjinha J. The redox interplay between nitrite and nitric oxide: From the gut to the brain. Redox Biol 2013;1:276-284.
8. Schreiber F, Stief P, Gieseke A, et al. Denitrification in human dental plaque. BMC Biol 2010;8:24.
9. Hyde ER, Andrade F, Vaksman Z, et al. Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: Implications for nitric oxide homeostasis. PLoS One 2014;9:e88645.
10. Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 2005;39:797-815.
11. Bryan NS. The potential use of salivary nitrite as a marker of NO status in humans. Nitric Oxide 2015;45:4-6.
12. Hendgen-Cotta UB, Kelm M, Rassaf T. Myoglobin functions in the heart. Free Radic Biol Med 2014;73:252-259.
13. Hendre AS, Shariff AK, Patil SR, Durgawale PP, Sontakke AV, Suryakar AN. Evaluation of oxidative stress and anti-oxidant status in essential hypertension. J Indian Med Assoc 2013;111:377-378, 380-381.
14. Han DH, Kim MS, Shin HS, Park KP, Kim HD. Association between periodontitis and salivary nitric oxide metabolites among community elderly Koreans. J Periodontol 2013;84:776-784.
15. Daghigh F, Borghaei RC, Thornton RD, Bee JH. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol 2002;73:392-400.
16. Van Leeuwen MP, Slot DE, Van der Weijden GA. Essential oils compared to chlorhexidine with respect to plaque and parameters of gingival inflammation: A systematic review. J Periodontol 2011;82:174-194.
17. Van Strydonck DA, Slot DE, Van der Velden U, Van der Weijden F. Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: A systematic review. J Clin Periodontol 2012;39:1042-1055.
18. Zandbergen D, Slot DE, Cobb CM, Van der Weijden FA. The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: A systematic review. J Periodontol 2013;84:332-351.
19. Kapil V, Haydar SMA, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med 2013;55:93-100.
20. Feres M, Gursky LC, Faveri M, Tsuzuki CO, Figueiredo LC. Clinical and microbiological benefits of strict supra-gingival plaque control as part of the active phase of periodontal therapy. J Clin Periodontol 2009;36:857-867.
21. Quirynen M, Mongardini C, de Soete M, et al. The role of chlorhexidine in the one-stage full-mouth disinfection treatment of patients with advanced adult periodontitis. Long-term clinical and microbiological observations. J Clin Periodontol 2000;27:578-589.
22. Mdala I, Olsen I, Haffajee AD, Socransky SS, de Blasio BF, Thoresen M. Multilevel analysis of bacterial counts from chronic periodontitis after root planing/scaling, surgery, and systemic and local antibiotics: 2-year results. J Oral Microbiol 2013;5:5-20.
23. Schwarzberg K, Le R, Bharti B, et al. The personal human oral microbiome obscures the effects of treatment on periodontal disease. PLoS One 2014;9:e86708.
24. Moinard C, Cynober L, de Bandt JP. Polyamines: Metabolism and implications in human diseases. Clin Nutr 2005;24:184-197.
25. Sudhamsu J, Crane BR. Bacterial nitric oxide syn-thases: What are they good for? Trends Microbiol 2009;17:212-218.
26. Pereira AL, Cortelli SC, Aquino DR, et al. Reduction of salivary arginine catabolic activity through periodontal therapy. Quintessence Int 2012;43:777-787.
27. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodon-tol 1999;4:1-6.
28. López NJ, Smith PC, Gutierrez J. Higher risk of preterm birth and low birth weight in women with periodontal disease. J Dent Res 2002;81:58-63.
29. Reher VG, Zenóbio EG, Costa FO, Reher P, Soares RV. Nitric oxide levels in saliva increase with severity of chronic periodontitis. J Oral Sci 2007;49:271-276.
30. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
31. Löe H, Silness J. Periodontal disease in pregnancy I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
32. Cortelli JR, Cortelli SC, Jordan S, Haraszthy VI, Zambon JJ. Prevalence of periodontal pathogens in Brazilians with aggressive or chronic periodontitis. J Clin Periodontol 2005;32:860-866.
33. Untergrasser A, Cutcutache I, Koressaar T, et al. Primer3 - New capabilities and interfaces. Nucleic Acids Research 2012;40:e115.
34. Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics 2007;23:1289-1291.
35. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Bio-chem 1982;126:131-138.
36. Romitelli F, Santini SA, Chierici E, et al. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: The importance of a correct removal of proteins in the Griess assay. J Chromatogr B Analyt Technol Biomed Life Sci 2007;851:257-267.
37. Milone G. Estatística geral e aplicada. São Paulo: Centage Learning; 2009.
38. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
39. Consolidated standards of reporting trials. Available at: http://www.consort-statement.org/Media/Default/Downloads/consort-statement.pdf. Accessed March 8, 2013.
40. Poorsattar Bejeh-Mir A, Parsian H, Akbari Khoram M, Ghasemi N, Bijani A, Khosravi-Samani M. Diagnostic role of salivary and GCF nitrite, nitrate and nitric oxide to distinguish healthy periodontium from gingivitis and periodontitis. Int J Mol Cell Med 2014;3:138-145.
41. Cortelli JR, Aquino DR, Cortelli SC, et al. Etiological analysis of initial colonization of periodontal pathogens in oral cavity. J Clin Microbiol 2008;46:1322-1329.
42. Abiko Y, Sato T, Mayanagi G, Takahashi N. Profiling of subgingival plaque biofilm microflora from peri-odontally healthy subjects and from subjects with peri-odontitis using quantitative real-time PCR. J Periodontal Res 2010;45:389-395.
43. Belstrøm D, Fiehn NE, Nielsen CH, et al. Differences in bacterial saliva profile between periodontitis patients and a control cohort. J Clin Periodontol 2014;41:104-112.
44. Ramseier CA, Kinney JS, Herr AE, et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009;80:436-446.
45. Peng X, Guo F, Ju F, Zhang T. Shifts in the microbial community, nitrifiers and denitrifiers in the biofilm in a full-scale rotating biological contactor. Environ Sci Technol 2014;48:8044-8052.
46. Hefti AF, Preshaw PM. Examiner alignment and assessment in clinical periodontal research. Periodontol 2000 2012;59:41-60.
47. Heitz-Mayfield LJ, Lang NP. Surgical and nonsurgical periodontal therapy. Learned and unlearned concepts. Periodontol 2000 2013;62:218-231.
48. Sánchez GA, Miozza VA, Delgado A, Busch L. Salivary IL-1b and PGE2 as biomarkers of periodontal status, before and after periodontal treatment. J Clin Peri-odontol 2013;40:1112-1117.
49. Teles RP, Likhari V, Socransky SS, Haffajee AD. Salivary cytokine levels in subjects with chronic peri-odontitis and in periodontally healthy individuals: A cross-sectional study. J Periodontal Res 2009;44:411-417.
50. Pereira AL, Franco GC, Cortelli SC, et al. Influence of periodontal status and periodontopathogens on levels of oral human β-defensin-2 in saliva. J Periodontol 2013;84:1445-1453.
51. Goodson JM, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982;9:472-481.
52. Benedetti F, Amanzio M. Mechanisms of the placebo response. Pulm Pharmacol Ther 2013;26:520-523.